TGRX-326 Pharmacokinetic Drug Interaction

Clinical trial NCT06294561 · COMPLETED

Trial details

NCT number: NCT06294561
Sponsor: Shenzhen TargetRx Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer

Start date: 2024-03-04
Primary completion: 2024-05-06
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.